Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trialGodelieve Goossens, M. Stas, Marc Jacquemin et al.|Annals of Oncology|2013Cited by 119
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective AnalysisPatrick Schöffski, Tim Wessels, Willy Coosemans et al.|Sarcoma|2020Cited by 39
9425 Administration of 24-hour intravenous infusions of trabectedin (Yondelis®) every 3 weeks in ambulatory patients with mesenchymal tumors via the disposable elastomeric pump Baxter LV10: a feasible, convenient, effective and patient-friendly palliative treatment optionPatrick Schöffski, A.T. van Oosterom, Linda Cerbone et al.|European Journal of Cancer Supplements|2009Cited by 1